A NOTCH3 pathogenic variant influences osteogenesis and can be targeted by antisense oligonucleotides in induced pluripotent stem cells.
Lateral Meningocele Syndrome (LMS), a disorder associated with NOTCH3 pathogenic variants, presents with neurological, craniofacial and skeletal abnormalities. Mouse models of the disease exhibit osteopenia that is ameliorated by the administration of Notch3 antisense oligonucleotides (ASO) targetin...
Saved in:
| Main Authors: | Ernesto Canalis, Jungeun Yu, Lauren Schilling, Paymaan Jafar-Nejad, Michele Carrer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0316644 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Skeletal muscle effects of antisense oligonucleotides targeting glycogen synthase 1 in a mouse model of Pompe disease
by: Lan Weiss, et al.
Published: (2025-04-01) -
Pharmacokinetics of antisense oligonucleotide drugs
by: M. R. Khaitov, et al.
Published: (2013-04-01) -
Molecular Profiling of Mouse Models of Loss or Gain of Function of the KCNT1 (Slack) Potassium Channel and Antisense Oligonucleotide Treatment
by: Fangxu Sun, et al.
Published: (2024-11-01) -
Tofersen and other antisense oligonucleotides in ALS
by: Albert Ludolph, et al.
Published: (2025-01-01) -
Antisense oligonucleotides targeting IRF4 alleviate psoriasis
by: Yanxia Yu, et al.
Published: (2025-07-01)